glp 1 and ibd 🚨 GLP-1 RA use in is rising fast In this 14-month repeated survey of patients with IBD: 📈 GLP-1 RA use rose 5-fold ⚖️ Median BMI fell from 35.3 → 31.2 Glucagon-like peptide 1 receptor (GLP-1R)

107 This poses a significant challenge for both the pharmaceutical industry and research activities

Daniele G, Iozzo P, Molina-Carrion M, Lancaster J, Ciociaro D, Cersosimo E, et al

Oral administration of NAD + precursors, such as tryptophan, nicotinic acid (niacin), nicotinamide, and nicotinamide riboside (NR), could increase tissue NAD + levels 525,526

The delivery notification email came two days after the package was already at my door, with a tracking number included

Learn how it works, who benefits most, and why this treatment is becoming a top choice for whole-body wellness

Caution is advised for patients with a history of pancreatitis, gallbladder disease, kidney disease, diabetic retinopathy, or gastrointestinal motility disorders